Company Information

CIN
Status
Date of Incorporation
12 November 1981
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
100,000
Authorised Capital
100,000

Directors

Raksha Talwar
Raksha Talwar
Director/Designated Partner
about 6 years ago
Gursaran Prashad Talwar
Gursaran Prashad Talwar
Director/Designated Partner
about 44 years ago

Past Directors

Vinod Kumar Jain
Vinod Kumar Jain
Director
about 7 years ago
Priyae Darshini Talwar
Priyae Darshini Talwar
Director
about 44 years ago

Patents

A Vaccine Composition And Method Of Froducing The Same

NA

"Fusion Protein Comprising An Fc Receptor Binding Polypeptide And Antigenic Polypeptide For Mediating An Immune Response"

The present invention provides a fusion protein comprising an Fc receptor binding polypeptide and an antigenic polypeptide. The fusion protein may further comprise a linker sequence or hinge portion which joins the Fc receptor binding polypeptide and the antigenic polypeptide. The Fc receptor binding polypeptide typ...

Vaccine Against Microbial Pathogens

NOT AVAILABLE

Method For The Production Of Protein Complexes And Vaccine Compositions Comprising The Same

The present invention relates to methods for the production of heat shock protein complexes for use in vaccine compositions. In particular there is provided a method for increasing the level and immunogenicity of heat shock protein complexes produced in cells by subjecting the cells to specific stress inducing stimu...

Method For The Purification Of Protein Complexes

The present invention provides an improved method for the purification of a mixture of complexes comprising a stress protein complexed to a peptide or peptide fragment from a source mixture  typically a cell lysate. The method of the invention provides for protein complexes to be purified using ion exchange chromato...

An In Vitro Method For Producing A Vaccine Comprising Cytokine Induced Heat Shock Protein And The Vaccine Produced Thereby

The present invention relates to a method for producing and isolating specific immunogenic heat shock protein from cancer cells or virally infected or recombinant cells and vaccines prepared from such proteins.

Vaccine Against Intra Cellular Pathogens

VACCINE AGAINST INTRA-CELLULAR PATHOGENSABSTRACTThe present invention relates to a method for producing and isolating specific immunogenic heat shock proteins induced by heat or tumour necrosis factor treatment of cells infected by intra-cellular pathogens; and vaccines prepared from such protein...

Documents

Form DPT-3-23032021-signed
Form MGT-7-05012021_signed
Form ADT-1-02012021_signed
Form AOC-4-02012021_signed
Form DIR-12-31122020
Optional Attachment-(1)-31122020
Copy of resolution passed by the company-31122020
Copy of written consent given by auditor-31122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-30122020
Directors report as per section 134(3)-30122020
List of share holders, debenture holders;-30122020
Form ADT-1-11062019_signed
Copy of the intimation sent by company-11062019
Copy of resolution passed by the company-11062019
Copy of written consent given by auditor-11062019
Evidence of cessation;-11032019
Form DIR-12-11032019_signed
Notice of resignation;-11032019
Notice of resignation;-02032019
Form DIR-12-02032019_signed
Evidence of cessation;-02032019
Form AOC-4-02032019_signed
Form MGT-7-28022019_signed
Form DIR-12-27022019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25022019
Directors report as per section 134(3)-25022019
List of share holders, debenture holders;-22022019
Optional Attachment-(2)-22022019
Optional Attachment-(1)-22022019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-22022019